{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:23:42Z","timestamp":1787498622418,"version":"build-2736575974"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"32","license":[{"start":{"date-parts":[[2014,10,27]],"date-time":"2014-10-27T00:00:00Z","timestamp":1414368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1038\/onc.2014.353","type":"journal-article","created":{"date-parts":[[2014,10,27]],"date-time":"2014-10-27T08:34:11Z","timestamp":1414398851000},"page":"4219-4228","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Anti-angiogenic pathway associations of the 3p21.3 mapped BLU gene in nasopharyngeal carcinoma"],"prefix":"10.1038","volume":"34","author":[{"given":"Y","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R L K Y","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K C","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Tung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H L","family":"Lung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W L","family":"Yau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A K L","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J M Y","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z F","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D Z","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z B","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X Y","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E J","family":"Stanbridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M L","family":"Lung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,27]]},"reference":[{"key":"BFonc2014353_CR1","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1073\/pnas.95.6.3042","volume":"95","author":"Y Cheng","year":"1998","unstructured":"Cheng Y, Poulos NE, Lung ML, Hampton G, Ou B, Lerman MI et al. Functional evidence for a nasopharyngeal carcinoma tumor suppressor gene that maps at chromosome 3p21.3. Proc Natl Acad Sci USA 1998; 95: 3042\u20133047.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2014353_CR2","doi-asserted-by":"publisher","first-page":"7283","DOI":"10.1038\/sj.onc.1210547","volume":"26","author":"LB Hesson","year":"2007","unstructured":"Hesson LB, Cooper WN, Latif F . Evaluation of the 3p21.3 tumour-suppressor gene cluster. Oncogene 2007; 26: 7283\u20137301.","journal-title":"Oncogene"},{"key":"BFonc2014353_CR3","first-page":"6116","volume":"60","author":"MI Lerman","year":"2000","unstructured":"Lerman MI, Minna JD . The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res 2000; 60: 6116\u20136133.","journal-title":"Cancer Res"},{"key":"BFonc2014353_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/77083","volume":"25","author":"R Dammann","year":"2000","unstructured":"Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP . Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 2000; 25: 315\u2013319.","journal-title":"Nat Genet"},{"key":"BFonc2014353_CR5","doi-asserted-by":"publisher","first-page":"6915","DOI":"10.1038\/sj.onc.1205835","volume":"21","author":"ER Zabarovsky","year":"2002","unstructured":"Zabarovsky ER, Lerman MI, Minna JD . Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene 2002; 21: 6915\u20136935.","journal-title":"Oncogene"},{"key":"BFonc2014353_CR6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/ijc.11166","volume":"106","author":"XQ Liu","year":"2003","unstructured":"Liu XQ, Chen HK, Zhang XS, Pan ZG, Li A, Feng QS et al. Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma. Int J Cancer 2003; 106: 60\u201365.","journal-title":"Int J Cancer"},{"key":"BFonc2014353_CR7","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.1038\/sj.onc.1207632","volume":"23","author":"GH Qiu","year":"2004","unstructured":"Qiu GH, Tan LK, Loh KS, Lim CY, Srivastava G, Tsai ST et al. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma. Oncogene 2004; 23: 4793\u20134806.","journal-title":"Oncogene"},{"key":"BFonc2014353_CR8","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1002\/ijc.22232","volume":"119","author":"WL Yau","year":"2006","unstructured":"Yau WL, Lung HL, Zabarovsky ER, Lerman MI, Sham JS, Chua DT et al. Functional studies of the chromosome 3p21.3 candidate tumor suppressor gene BLU\/ZMYND10 in nasopharyngeal carcinoma. Int J Cancer 2006; 119: 2821\u20132826.","journal-title":"Int J Cancer"},{"key":"BFonc2014353_CR9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/1471-2407-12-267","volume":"12","author":"X Zhang","year":"2012","unstructured":"Zhang X, Liu H, Li B, Huang P, Shao J, He Z . Tumor suppressor BLU inhibits proliferation of nasopharyngeal carcinoma cells by regulation of cell cycle, c-Jun N-terminal kinase and the cyclin D1 promoter. BMC Cancer 2012; 12: 267.","journal-title":"BMC Cancer"},{"key":"BFonc2014353_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/ijc.20714","volume":"114","author":"CJ Marsit","year":"2005","unstructured":"Marsit CJ, Kim DH, Liu M, Hinds PW, Wiencke JK, Nelson HH et al. Hypermethylation of RASSF1A and BLU tumor suppressor genes in non-small cell lung cancer: implications for tobacco smoking during adolescence. Int J Cancer 2005; 114: 219\u2013223.","journal-title":"Int J Cancer"},{"key":"BFonc2014353_CR11","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1038\/sj.onc.1206243","volume":"22","author":"A Agathanggelou","year":"2003","unstructured":"Agathanggelou A, Dallol A, Zochbauer-Muller S, Morrissey C, Honorio S, Hesson L et al. Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers. Oncogene 2003; 22: 1580\u20131588.","journal-title":"Oncogene"},{"key":"BFonc2014353_CR12","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1038\/sj.onc.1207407","volume":"23","author":"L Hesson","year":"2004","unstructured":"Hesson L, Bieche I, Krex D, Criniere E, Hoang-Xuan K, Maher ER et al. Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas. Oncogene 2004; 23: 2408\u20132419.","journal-title":"Oncogene"},{"key":"BFonc2014353_CR13","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.ygyno.2006.10.003","volume":"104","author":"HC Lai","year":"2007","unstructured":"Lai HC, Lin YW, Chang CC, Wang HC, Chu TW, Yu MH et al. Hypermethylation of two consecutive tumor suppressor genes, BLU and RASSF1A, located at 3p21.3 in cervical neoplasias. Gynecol Oncol 2007; 104: 629\u2013635.","journal-title":"Gynecol Oncol"},{"key":"BFonc2014353_CR14","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.canlet.2005.03.036","volume":"234","author":"LoPH Yi","year":"2006","unstructured":"Yi Lo PH, Chung Leung AC, Xiong W, Law S, Duh FM, Lerman MI et al. Expression of candidate chromosome 3p21.3 tumor suppressor genes and down-regulation of BLU in some esophageal squamous cell carcinomas. Cancer Lett 2006; 234: 184\u2013192.","journal-title":"Cancer Lett"},{"key":"BFonc2014353_CR15","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/ijc.20944","volume":"115","author":"I Tischoff","year":"2005","unstructured":"Tischoff I, Markwarth A, Witzigmann H, Uhlmann D, Hauss J, Mirmohammadsadegh A et al. Allele loss and epigenetic inactivation of 3p21.3 in malignant liver tumors. Int J Cancer 2005; 115: 684\u2013689.","journal-title":"Int J Cancer"},{"key":"BFonc2014353_CR16","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00432-012-1151-0","volume":"138","author":"Y Yang","year":"2012","unstructured":"Yang Y, Zhang Q, Xu F, Wu L, He Q, Li X . Tumor suppressor gene BLU is frequently downregulated by promoter hypermethylation in myelodysplastic syndrome. J Cancer Res Clin Oncol 2012; 138: 729\u2013737.","journal-title":"J Cancer Res Clin Oncol"},{"key":"BFonc2014353_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.bbrc.2013.04.061","volume":"435","author":"ST Park","year":"2013","unstructured":"Park ST, Byun HJ, Kim BR, Dong SM, Park SH, Jang PR et al. Tumor suppressor BLU promotes paclitaxel antitumor activity by inducing apoptosis through the down-regulation of Bcl-2 expression in tumorigenesis. Biochem Biophys Res Commun 2013; 435: 153\u2013159.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFonc2014353_CR18","doi-asserted-by":"publisher","first-page":"5567","DOI":"10.1158\/0008-5472.CAN-09-4510","volume":"70","author":"PH Lo","year":"2010","unstructured":"Lo PH, Lung HL, Cheung AK, Apte SS, Chan KW, Kwong FM et al. Extracellular protease ADAMTS9 suppresses esophageal and nasopharyngeal carcinoma tumor formation by inhibiting angiogenesis. Cancer Res 2010; 70: 5567\u20135576.","journal-title":"Cancer Res"},{"key":"BFonc2014353_CR19","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/ijc.23528","volume":"123","author":"HL Lung","year":"2008","unstructured":"Lung HL, Lo PH, Xie D, Apte SS, Cheung AK, Cheng Y et al. Characterization of a novel epigenetically-silenced, growth-suppressive gene, ADAMTS9, and its association with lymph node metastases in nasopharyngeal carcinoma. Int J Cancer 2008; 123: 401\u2013408.","journal-title":"Int J Cancer"},{"key":"BFonc2014353_CR20","doi-asserted-by":"publisher","first-page":"38923","DOI":"10.1074\/jbc.M110.172304","volume":"285","author":"S Kaur","year":"2010","unstructured":"Kaur S, Martin-Manso G, Pendrak ML, Garfield SH, Isenberg JS, Roberts DD . Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47. J Biol Chem 2010; 285: 38923\u201338932.","journal-title":"J Biol Chem"},{"key":"BFonc2014353_CR21","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.2353\/ajpath.2010.090655","volume":"176","author":"BH Koo","year":"2010","unstructured":"Koo BH, Coe DM, Dixon LJ, Somerville RP, Nelson CM, Wang LW et al. ADAMTS9 is a cell-autonomously acting, anti-angiogenic metalloprotease expressed by microvascular endothelial cells. Am J Pathol 2010; 176: 1494\u20131504.","journal-title":"Am J Pathol"},{"key":"BFonc2014353_CR22","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1158\/0008-5472.CAN-09-3094","volume":"70","author":"YJ Lee","year":"2010","unstructured":"Lee YJ, Koch M, Karl D, Torres-Collado AX, Fernando NT, Rothrock C et al. Variable inhibition of thrombospondin 1 against liver and lung metastases through differential activation of metalloproteinase ADAMTS1. Cancer Res 2010; 70: 948\u2013956.","journal-title":"Cancer Res"},{"key":"BFonc2014353_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/bies.950180113","volume":"18","author":"GP Tuszynski","year":"1996","unstructured":"Tuszynski GP, Nicosia RF . The role of thrombospondin-1 in tumor progression and angiogenesis. Bioessays 1996; 18: 71\u201376.","journal-title":"Bioessays"},{"key":"BFonc2014353_CR24","doi-asserted-by":"publisher","first-page":"e13442","DOI":"10.1371\/journal.pone.0013442","volume":"5","author":"W Ji","year":"2010","unstructured":"Ji W, Zhang W, Xiao W . E2F-1 directly regulates thrombospondin 1 expression. PLoS ONE 2010; 5: e13442.","journal-title":"PLoS ONE"},{"key":"BFonc2014353_CR25","doi-asserted-by":"publisher","first-page":"10357","DOI":"10.1158\/0008-5472.CAN-06-2496","volume":"66","author":"EV Yang","year":"2006","unstructured":"Yang EV, Sood AK, Chen M, Li Y, Eubank TD, Marsh CB et al. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res 2006; 66: 10357\u201310364.","journal-title":"Cancer Res"},{"key":"BFonc2014353_CR26","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1002\/ijc.25855","volume":"129","author":"KC Chan","year":"2011","unstructured":"Chan KC, Ko JM, Lung HL, Sedlacek R, Zhang ZF, Luo DZ et al. Catalytic activity of Matrix metalloproteinase-19 is essential for tumor suppressor and anti-angiogenic activities in nasopharyngeal carcinoma. Int J Cancer 2011; 129: 1826\u20131837.","journal-title":"Int J Cancer"},{"key":"BFonc2014353_CR27","doi-asserted-by":"publisher","first-page":"4605","DOI":"10.1182\/blood-2009-09-242065","volume":"115","author":"A Zaslavsky","year":"2010","unstructured":"Zaslavsky A, Baek KH, Lynch RC, Short S, Grillo J, Folkman J et al. Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis. Blood 2010; 115: 4605\u20134613.","journal-title":"Blood"},{"key":"BFonc2014353_CR28","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1177\/153537020222600803","volume":"226","author":"I Sargiannidou","year":"2001","unstructured":"Sargiannidou I, Zhou J, Tuszynski GP . The role of thrombospondin-1 in tumor progression. Exp Biol Med (Maywood) 2001; 226: 726\u2013733.","journal-title":"Exp Biol Med (Maywood)"},{"key":"BFonc2014353_CR29","doi-asserted-by":"publisher","first-page":"10649","DOI":"10.1073\/pnas.1004934107","volume":"107","author":"C Nucera","year":"2010","unstructured":"Nucera C, Porrello A, Antonello ZA, Mekel M, Nehs MA, Giordano TJ et al. B-Raf(V600E) and thrombospondin-1 promote thyroid cancer progression. Proc Natl Acad Sci USA 2010; 107: 10649\u201310654.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2014353_CR30","doi-asserted-by":"publisher","first-page":"12249","DOI":"10.3390\/ijms140612249","volume":"14","author":"Y Miyata","year":"2013","unstructured":"Miyata Y, Sakai H . Thrombospondin-1 in urological cancer: pathological role, clinical significance, and therapeutic prospects. Int J Mol Sci 2013; 14: 12249\u201312272.","journal-title":"Int J Mol Sci"},{"key":"BFonc2014353_CR31","doi-asserted-by":"publisher","first-page":"6023","DOI":"10.1073\/pnas.082110999","volume":"99","author":"M Ancelin","year":"2002","unstructured":"Ancelin M, Buteau-Lozano H, Meduri G, Osborne-Pellegrin M, Sordello S, Plouet J et al. A dynamic shift of VEGF isoforms with a transient and selective progesterone-induced expression of VEGF189 regulates angiogenesis and vascular permeability in human uterus. Proc Natl Acad Sci USA 2002; 99: 6023\u20136028.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2014353_CR32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.yexcr.2005.05.022","volume":"309","author":"MA Herve","year":"2005","unstructured":"Herve MA, Buteau-Lozano H, Mourah S, Calvo F, Perrot-Applanat M . VEGF189 stimulates endothelial cells proliferation and migration in vitro and up-regulates the expression of Flk-1\/KDR mRNA. Exp Cell Res 2005; 309: 24\u201331.","journal-title":"Exp Cell Res"},{"key":"BFonc2014353_CR33","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/CAD.0b013e3283363980","volume":"21","author":"X Peng","year":"2010","unstructured":"Peng X, Li W, Tan G . Reversal of taxol resistance by cisplatin in nasopharyngeal carcinoma by upregulating thromspondin-1 expression. Anticancer Drugs 2010; 21: 381\u2013388.","journal-title":"Anticancer Drugs"},{"key":"BFonc2014353_CR34","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/labinvest.3700053","volume":"84","author":"M Ancelin","year":"2004","unstructured":"Ancelin M, Chollet-Martin S, Herve MA, Legrand C, El Benna J, Perrot-Applanat M . Vascular endothelial growth factor VEGF189 induces human neutrophil chemotaxis in extravascular tissue via an autocrine amplification mechanism. Lab Invest 2004; 84: 502\u2013512.","journal-title":"Lab Invest"},{"key":"BFonc2014353_CR35","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/onc.2011.272","volume":"31","author":"EW Law","year":"2012","unstructured":"Law EW, Cheung AK, Kashuba VI, Pavlova TV, Zabarovsky ER, Lung HL et al. Anti-angiogenic and tumor-suppressive roles of candidate tumor-suppressor gene, Fibulin-2, in nasopharyngeal carcinoma. Oncogene 2012; 31: 728\u2013738.","journal-title":"Oncogene"},{"key":"BFonc2014353_CR36","first-page":"29","volume":"1825","author":"B Bauvois","year":"2012","unstructured":"Bauvois B . New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression. Biochim Biophys Acta 2012; 1825: 29\u201336.","journal-title":"Biochim Biophys Acta"},{"key":"BFonc2014353_CR37","first-page":"8511","volume":"63","author":"D Trudel","year":"2003","unstructured":"Trudel D, Fradet Y, Meyer F, Harel F, Tetu B . Significance of MMP-2 expression in prostate cancer: an immunohistochemical study. Cancer Res 2003; 63: 8511\u20138515.","journal-title":"Cancer Res"},{"key":"BFonc2014353_CR38","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s12079-009-0060-8","volume":"3","author":"P Bornstein","year":"2009","unstructured":"Bornstein P . Thrombospondins function as regulators of angiogenesis. J Cell Commun Signal 2009; 3: 189\u2013200.","journal-title":"J Cell Commun Signal"},{"key":"BFonc2014353_CR39","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/jid.2011.343","volume":"132","author":"TA Wilgus","year":"2012","unstructured":"Wilgus TA, DiPietro LA . Complex Roles for VEGF in Dermal Wound Healing. J Invest Dermatol 2012; 132: 493\u2013494.","journal-title":"J Invest Dermatol"},{"key":"BFonc2014353_CR40","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/1479-5876-9-216","volume":"9","author":"M Heusinkveld","year":"2011","unstructured":"Heusinkveld M, van der Burg SH . Identification and manipulation of tumor associated macrophages in human cancers. J Transl Med 2011; 9: 216.","journal-title":"J Transl Med"},{"key":"BFonc2014353_CR41","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/PAI.0b013e31827c00e1","volume":"21","author":"DR Mane","year":"2013","unstructured":"Mane DR, Kale AD, Angadi P, Hallikerimath S . Expression of cytokeratin subtypes: MMP-9, p53, and alphaSMA to differentiate basaloid squamous cell carcinoma from other basaloid tumors of the oral cavity. Appl Immunohistochem Mol Morphol 2013; 21: 431\u2013443.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"BFonc2014353_CR42","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/ajh.21745","volume":"85","author":"A Raza","year":"2010","unstructured":"Raza A, Franklin MJ, Dudek AZ . Pericytes and vessel maturation during tumor angiogenesis and metastasis. Am J Hematol 2010; 85: 593\u2013598.","journal-title":"Am J Hematol"},{"key":"BFonc2014353_CR43","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/(SICI)1098-2264(200005)28:1<82::AID-GCC10>3.0.CO;2-8","volume":"28","author":"Y Cheng","year":"2000","unstructured":"Cheng Y, Stanbridge EJ, Kong H, Bengtsson U, Lerman MI, Lung ML . A functional investigation of tumor suppressor gene activities in a nasopharyngeal carcinoma cell line HONE1 using a monochromosome transfer approach. Genes Chromosomes Cancer 2000; 28: 82\u201391.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFonc2014353_CR44","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.semcancer.2011.11.002","volume":"22","author":"HL Lung","year":"2012","unstructured":"Lung HL, Cheung AK, Ko JM, Cheng Y, Stanbridge EJ, Lung ML . Deciphering the molecular genetic basis of NPC through functional approaches. Semin Cancer Biol 2012; 22: 87\u201395.","journal-title":"Semin Cancer Biol"},{"key":"BFonc2014353_CR45","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/(SICI)1097-0215(20000120)89:1<51::AID-IJC9>3.0.CO;2-8","volume":"89","author":"B Linderholm","year":"2000","unstructured":"Linderholm B, Lindh B, Tavelin B, Grankvist K, Henriksson R . p53 and vascular-endothelial-growth-factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma. Int J Cancer 2000; 89: 51\u201362.","journal-title":"Int J Cancer"},{"key":"BFonc2014353_CR46","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0945-053X(02)00010-0","volume":"21","author":"MA Ferrari do Outeiro-Bernstein","year":"2002","unstructured":"Ferrari do Outeiro-Bernstein MA, Nunes SS, Andrade AC, Alves TR, Legrand C, Morandi V . A recombinant NH(2)-terminal heparin-binding domain of the adhesive glycoprotein, thrombospondin-1, promotes endothelial tube formation and cell survival: a possible role for syndecan-4 proteoglycan. Matrix Biol 2002; 21: 311\u2013324.","journal-title":"Matrix Biol"},{"key":"BFonc2014353_CR47","doi-asserted-by":"publisher","first-page":"a006627","DOI":"10.1101\/cshperspect.a006627","volume":"2","author":"PR Lawler","year":"2012","unstructured":"Lawler PR, Lawler J . Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2. Cold Spring Harb Perspect Med 2012; 2: a006627.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"BFonc2014353_CR48","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1158\/0008-5472.828.65.3","volume":"65","author":"M Abe","year":"2005","unstructured":"Abe M, Ohira M, Kaneda A, Yagi Y, Yamamoto S, Kitano Y et al. CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas. Cancer Res 2005; 65: 828\u2013834.","journal-title":"Cancer Res"},{"key":"BFonc2014353_CR49","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/ncb2767","volume":"15","author":"CM Ghajar","year":"2013","unstructured":"Ghajar CM, Peinado H, Mori H, Matei IR, Evason KJ, Brazier H et al. The perivascular niche regulates breast tumour dormancy. Nat Cell Biol 2013; 15: 807\u2013817.","journal-title":"Nat Cell Biol"},{"key":"BFonc2014353_CR50","first-page":"2595","volume":"8","author":"EP Hui","year":"2002","unstructured":"Hui EP, Chan AT, Pezzella F, Turley H, To KF, Poon TC et al. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival. Clin Cancer Res 2002; 8: 2595\u20132604.","journal-title":"Clin Cancer Res"},{"key":"BFonc2014353_CR51","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.virusres.2005.07.010","volume":"115","author":"SM Krishna","year":"2006","unstructured":"Krishna SM, James S, Balaram P . Expression of VEGF as prognosticator in primary nasopharyngeal cancer and its relation to EBV status. Virus Res 2006; 115: 85\u201390.","journal-title":"Virus Res"},{"key":"BFonc2014353_CR52","unstructured":"Lung HL, Cheung AKL, Ko JMY, Cheng Y, Lung ML . Identification of tumor suppressor genes via cell fusion and chromosomal transfer. In: Cheng Y (ed.) Tumor Suppressor Genes. InTech: Croatia 2012, pp 53\u201378."},{"key":"BFonc2014353_CR53","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1126\/science.7521539","volume":"265","author":"KM Dameron","year":"1994","unstructured":"Dameron KM, Volpert OV, Tainsky MA, Bouck N . Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 1994; 265: 1582\u20131584.","journal-title":"Science"},{"key":"BFonc2014353_CR54","doi-asserted-by":"publisher","first-page":"6516","DOI":"10.1073\/pnas.89.14.6516","volume":"89","author":"Y Sun","year":"1992","unstructured":"Sun Y, Hegamyer G, Cheng YJ, Hildesheim A, Chen JY, Chen IH et al. An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma. Proc Natl Acad Sci USA 1992; 89: 6516\u20136520.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2014353_CR55","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1471-2121-14-44","volume":"14","author":"Y Cheng","year":"2013","unstructured":"Cheng Y, Cheung AK, Ko JM, Phoon YP, Chiu PM, Lo PH et al. Physiological \u03b2-catenin signaling controls self-renewal networks and generation of stem-like cells from nasopharyngeal carcinoma. BMC Cell Biol 2013; 14: 44.","journal-title":"BMC Cell Biol"},{"key":"BFonc2014353_CR56","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.biocel.2013.04.001","volume":"45","author":"HJ Yoo","year":"2013","unstructured":"Yoo HJ, Kim BR, Byun HJ, Park SY, Rho SB . BLU enhances the effects of anti-angiogenic activity in combination with gemcitabine-based chemotherapeutic agents. Int J Biochem Cell Biol 2013; 45: 1236\u20131245.","journal-title":"Int J Biochem Cell Biol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/onc2014353.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/onc2014353","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/onc2014353.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T12:14:55Z","timestamp":1689596095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2014353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,27]]},"references-count":56,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["BFonc2014353"],"URL":"https:\/\/doi.org\/10.1038\/onc.2014.353","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,27]]},"assertion":[{"value":"9 March 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}